Lack of involvement of P-glycoprotein (P-gp) in pemphigus patients with poor response to steroid therapy

Journal of Dermatological Science

Volumn 28, Issue 3, 2002, Pages 219-226

  De La Fuente, Hortensia ^a   Baranda, Lourdes ^b   Hernández, Martha I ^a   Torres Alvarez, Bertha ^b   Llorente, Luis ^c   Layseca, Esther ^a   González Amaro, Roberto ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b HOSPITAL CENTRAL DR IGNACIO MORONES PRIETO   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Bullous diseases; Glucocorticoids; Lymphocytes; Multidrug resistance

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; GLYCOPROTEIN P; MESSENGER RNA; STEROID;

ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN CELL; LYMPHOID CELL; MALE; MONONUCLEAR CELL; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROID THERAPY;

AGED; AGED, 80 AND OVER; DRUG RESISTANCE, MULTIPLE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; MONOCYTES; P-GLYCOPROTEIN; PEMPHIGUS; RNA, MESSENGER;

EID: 0036129289     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(01)00169-4     Document Type: Article

References (28)

1. Pemphigus. A 20-year review of 107 patients treated with corticosteroids
2. Successful treatment of corticosteroid-resistant pemphigus with high-dose intravenous immunoglobulins
3. Mycophenolate mofetil in autoimmune and inflammatory skin disorders
4. Function, evolution and structure of multidrug resistance protein
5. Overexpression of a transporter gene in a multidrug resistant human lung cancer line
6. The direct activation of human multidrug resistance gene (MDR) by anticancer agents
7. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport
8. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues
9. Subpopulation of normal peripheral blood and bone marrow cells express a functional multidrug resistance phenotype
10. Expression and activity of the multidrug resistance P-gp in human peripheral blood lymphocytes
11. Expression and activity of P-gp, a multidrug efflux pump in human hematopoyetic stem cells
12. Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II. Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control
13. Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part 1: Increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcomes
14. Expression of an mdr gene is associated with a new form or resistance to dexamethasone induced apoptosis
15. The detection of Rhodamine 123 efflux at low levels of drug resistance
16. Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines
17. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion
18. Active outward transport of Daunomycin in resistant Ehrlich ascitis tumor cells
19. Reduced permeability in CHO cell as a mechanisms of resistance to colchicine
20. P-glycoprotein in adult hematologic malignancies
21. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A treated patients
22. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris
23. Combination of IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids
24. IL-2 and IL-4 counteract budesonide inhibition of GM-CSF and IL-10, but not of IL-8, IL-12 or TNF-alpha production by human mononuclear blood cells
25. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris
26. Evidence for cell-mediated immune mechanisms in the pathology of pemphigus
27. Recurrence of pemphigus vulgaris associated with interleukin 2 therapy
28. A case of fatal pemphigus vulgaris in association with beta interferon and interleukin-2 therapy